Close Menu
October 23, 2019
Sponsored by
Swift Biosciences

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

GenomeWebinar

Research Specialist,
Perelman School of Medicine at the University of Pennsylvania

Assistant Professor, Department of Genetics,
University of Pennsylvania

Senior Product Manager
Swift Biosciences

This webinar illustrates how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries. 

Our speaker, Jennifer Flournoy of Perelman School of Medicine at the University of Pennsylvania, discusses a single-cell methylation approach from Swift Bioscience that her team is using to study pediatric leukemia and gliomas.

Swift's Accel-NGS Adaptase Module enables construction of next-generation sequencing libraries from bisulfite-converted, single-stranded DNA from single cells. This module is optimized to maximize the recovery of DNA containing uracil residues and low concentrations of AT-rich template. The resultant libraries consistently exhibit superior complexity with reduced composition bias to provide a more faithful representation of the methylome. This approach has demonstrated greater than 2-fold increase in read mapping rate as compared to other methods, significantly improving the data output per run while reducing the sample sequencing cost.

In this webinar, Jennifer Flournoy and her colleague Dr. Hao Wu details how they are using this single-cell methylation method to contribute to the generation of multi-omic human tumor atlases and to inform therapeutic approaches for pediatric cancers.

Sponsored by

Stephen Hahn, the nominee to lead the US Food and Drug Administration, underwent a Senate confirmation hearing yesterday, the Washington Post reports.

The US Food and Drug Administration has approved an RNA interference drug to treat acute hepatic porphyria.

Gizmodo looks over the past decade of consumer DNA testing to find the field to be lacking.

In Nature this week: native RNA sequencing and analysis of a human poly(A) transcriptome, nanopore sequencing-based method to analyze short tandem repeat expansions, and more.